Back to results
US 6,548,556 B2Granted
Stable enzymatic wound debrider
AssigneeHealthpoint, Ltd.
InventorsDavid W. Hobson, David P. Jones, Katarzyna Koster, Pilar P. Duque
Life of this patent
Estimating the term…
Abstract
This invention relates to an enzymatic anhydrous hydrophilic wound debrider that uses in combination a proteolytic enzyme and an anhydrous hydrophilic poloxamer carrier.
Claims14
An enzymatic wound debrider, consisting essentially of:
- an anhydrous hydrophilic poloxamer carrier, and
- a small but debridement effective amount of one or more proteolytic enzymes.
The method of enzymatic wound debridement, consisting essentially of:
- applying to a wound in need of debridement a combination of an anhydrous hydrophilic poloxamer gel and a small but debridement effective amount of one or more proteoplytic enzymes.
Dependencies are inferred from the claim text.